← Open Payments lookup

JAMES WEIDEL: Open Payments

NPI 1073790564 · CATSKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,759 in 100 payments from 12 companies in 2025. Trend: 2023 $345 · 2024 $597 · 2025 $1,759

Food & beverage: $1,759
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$327
E.R. Squibb & Sons, L.L.C.16$242
Vanda Pharmaceuticals Inc.12$235
Alkermes, Inc.16$214
ABBVIE INC.11$196
Otsuka America Pharmaceutical, Inc.9$181
Axsome Therapeutics, Inc.10$154
Supernus Pharmaceuticals, Inc.5$100
Braeburn Inc.2$36
Janssen Pharmaceuticals, Inc2$30

Products named: CAPLYTA, COBENFY, FANAPT, ARISTADA, REXULTI, VRAYLAR, Auvelity, Qelbree.

Industry payments across NY — which companies pay providers there.